Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

ARDT vs UNH vs CVS vs HCA vs CI

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ARDT
Ardent Health Partners, LLC

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$1.41B
5Y Perf.-43.4%
UNH
UnitedHealth Group Incorporated

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$335.60B
5Y Perf.-34.0%
CVS
CVS Health Corporation

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$111.40B
5Y Perf.+50.1%
HCA
HCA Healthcare, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$95.95B
5Y Perf.+19.9%
CI
Cigna Corporation

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$74.85B
5Y Perf.-17.4%

ARDT vs UNH vs CVS vs HCA vs CI — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ARDT logoARDT
UNH logoUNH
CVS logoCVS
HCA logoHCA
CI logoCI
IndustryMedical - Care FacilitiesMedical - Healthcare PlansMedical - Healthcare PlansMedical - Care FacilitiesMedical - Healthcare Plans
Market Cap$1.41B$335.60B$111.40B$95.95B$74.85B
Revenue (TTM)$6.43B$449.71B$407.90B$75.60B$277.94B
Net Income (TTM)$134M$12.04B$2.93B$6.78B$6.29B
Gross Margin60.5%18.8%13.9%41.5%9.3%
Operating Margin8.9%4.2%1.5%15.8%3.4%
Forward P/E9.0x20.2x12.4x14.4x9.4x
Total Debt$2.26B$78.39B$93.59B$50.20B$31.46B
Cash & Equiv.$710M$24.36B$8.51B$1.04B$7.68B

ARDT vs UNH vs CVS vs HCA vs CILong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ARDT
UNH
CVS
HCA
CI
StockJul 24May 26Return
Ardent Health Partn… (ARDT)10056.6-43.4%
UnitedHealth Group … (UNH)10066.0-34.0%
CVS Health Corporat… (CVS)100150.1+50.1%
HCA Healthcare, Inc. (HCA)100119.9+19.9%
Cigna Corporation (CI)10082.6-17.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: ARDT vs UNH vs CVS vs HCA vs CI

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CVS leads in 3 of 7 categories (5-stock set), making it the strongest pick for capital preservation and lower volatility and dividend income and shareholder returns. HCA Healthcare, Inc. is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. ARDT and UNH also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
ARDT
Ardent Health Partners, LLC
The Value Play

ARDT ranks third and is worth considering specifically for value.

  • Lower P/E (9.0x vs 9.4x)
Best for: value
UNH
UnitedHealth Group Incorporated
The Insurance Pick

UNH is the clearest fit if your priority is growth.

  • 11.8% revenue growth vs ARDT's 6.0%
Best for: growth
CVS
CVS Health Corporation
The Insurance Pick

CVS carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.

  • Dividend streak 0 yrs, beta 0.05, yield 3.1%
  • Lower volatility, beta 0.05, current ratio 0.84x
  • Beta 0.05, yield 3.1%, current ratio 0.84x
  • Beta 0.05 vs ARDT's 1.40, lower leverage
Best for: income & stability and sleep-well-at-night
HCA
HCA Healthcare, Inc.
The Long-Run Compounder

HCA is the #2 pick in this set and the best alternative if long-term compounding is your priority.

  • 450.5% 10Y total return vs CI's 136.5%
  • 9.0% margin vs CVS's 0.7%
  • 11.3% ROA vs CVS's 1.1%, ROIC 19.9% vs 5.0%
Best for: long-term compounding
CI
Cigna Corporation
The Insurance Pick

CI is the clearest fit if your priority is growth exposure.

  • Rev growth 11.3%, EPS growth 82.9%, 3Y rev CAGR 15.1%
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthUNH logoUNH11.8% revenue growth vs ARDT's 6.0%
ValueARDT logoARDTLower P/E (9.0x vs 9.4x)
Quality / MarginsHCA logoHCA9.0% margin vs CVS's 0.7%
Stability / SafetyCVS logoCVSBeta 0.05 vs ARDT's 1.40, lower leverage
DividendsCVS logoCVS3.1% yield, vs UNH's 2.4%, (1 stock pays no dividend)
Momentum (1Y)CVS logoCVS+34.7% vs ARDT's -30.5%
Efficiency (ROA)HCA logoHCA11.3% ROA vs CVS's 1.1%, ROIC 19.9% vs 5.0%

ARDT vs UNH vs CVS vs HCA vs CI — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ARDTArdent Health Partners, LLC
FY 2025
Reportable Segment
100.0%$6.3B
UNHUnitedHealth Group Incorporated
FY 2025
Unitedhealthcare
94.4%$332.4B
Optumhealth
5.6%$19.8B
CVSCVS Health Corporation
FY 2025
Pharmacy Revenue
58.9%$229.0B
Premiums
34.6%$134.8B
Front Store Revenue
5.5%$21.5B
Product and Service, Other
1.0%$3.9B
HCAHCA Healthcare, Inc.
FY 2025
Managed Care And Other Insurers
50.5%$37.0B
Managed Medicare
18.4%$13.4B
Medicare
15.4%$11.3B
Medicaid
8.1%$5.9B
Managed Medicaid
5.0%$3.7B
International
2.5%$1.9B
CICigna Corporation
FY 2025
Evernorth
83.2%$235.0B
Cigna Healthcare
16.8%$47.4B

ARDT vs UNH vs CVS vs HCA vs CI — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHCALAGGINGUNH

Income & Cash Flow (Last 12 Months)

HCA leads this category, winning 3 of 6 comparable metrics.

UNH is the larger business by revenue, generating $449.7B annually — 70.0x ARDT's $6.4B. HCA is the more profitable business, keeping 9.0% of every revenue dollar as net income compared to CVS's 0.7%. On growth, ARDT holds the edge at +7.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricARDT logoARDTArdent Health Par…UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…HCA logoHCAHCA Healthcare, I…CI logoCICigna Corporation
RevenueTrailing 12 months$6.4B$449.7B$407.9B$75.6B$277.9B
EBITDAEarnings before interest/tax$733M$23.2B$10.5B$15.5B$12.1B
Net IncomeAfter-tax profit$134M$12.0B$2.9B$6.8B$6.3B
Free Cash FlowCash after capex$214M$19.7B$7.4B$7.7B$7.7B
Gross MarginGross profit ÷ Revenue+60.5%+18.8%+13.9%+41.5%+9.3%
Operating MarginEBIT ÷ Revenue+8.9%+4.2%+1.5%+15.8%+3.4%
Net MarginNet income ÷ Revenue+2.1%+2.7%+0.7%+9.0%+2.3%
FCF MarginFCF ÷ Revenue+3.3%+4.4%+1.8%+10.2%+2.8%
Rev. Growth (YoY)Latest quarter vs prior year+7.0%+2.0%+6.2%+6.7%+4.6%
EPS Growth (YoY)Latest quarter vs prior year-3.4%+0.7%+63.1%+44.6%+29.1%
HCA leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

ARDT leads this category, winning 6 of 6 comparable metrics.

At 10.3x trailing earnings, ARDT trades at a 84% valuation discount to CVS's 62.8x P/E. On an enterprise value basis, ARDT's 6.2x EV/EBITDA is more attractive than UNH's 16.7x.

MetricARDT logoARDTArdent Health Par…UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…HCA logoHCAHCA Healthcare, I…CI logoCICigna Corporation
Market CapShares × price$1.4B$335.6B$111.4B$95.9B$74.9B
Enterprise ValueMkt cap + debt − cash$3.0B$389.6B$196.5B$145.1B$98.6B
Trailing P/EPrice ÷ TTM EPS10.29x27.95x62.81x15.12x12.81x
Forward P/EPrice ÷ next-FY EPS est.8.99x20.19x12.39x14.40x9.36x
PEG RatioP/E ÷ EPS growth rate0.72x
EV / EBITDAEnterprise value multiple6.17x16.70x13.11x9.37x8.39x
Price / SalesMarket cap ÷ Revenue0.22x0.75x0.28x1.27x0.27x
Price / BookPrice ÷ Book value/share0.83x3.31x1.47x1.80x
Price / FCFMarket cap ÷ FCF5.47x20.88x14.27x12.47x8.92x
ARDT leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

CI leads this category, winning 4 of 9 comparable metrics.

CI delivers a 15.1% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $4 for CVS. CI carries lower financial leverage with a 0.75x debt-to-equity ratio, signaling a more conservative balance sheet compared to ARDT's 1.34x. On the Piotroski fundamental quality scale (0–9), CI scores 8/9 vs CVS's 5/9, reflecting strong financial health.

MetricARDT logoARDTArdent Health Par…UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…HCA logoHCAHCA Healthcare, I…CI logoCICigna Corporation
ROE (TTM)Return on equity+8.0%+11.5%+3.9%+15.1%
ROA (TTM)Return on assets+2.6%+3.9%+1.1%+11.3%+4.1%
ROICReturn on invested capital+7.5%+9.2%+5.0%+19.9%+10.4%
ROCEReturn on capital employed+7.9%+9.7%+6.1%+27.0%+9.2%
Piotroski ScoreFundamental quality 0–966578
Debt / EquityFinancial leverage1.34x0.77x1.24x0.75x
Net DebtTotal debt minus cash$1.6B$54.0B$85.1B$49.2B$23.8B
Cash & Equiv.Liquid assets$710M$24.4B$8.5B$1.0B$7.7B
Total DebtShort + long-term debt$2.3B$78.4B$93.6B$50.2B$31.5B
Interest CoverageEBIT ÷ Interest expense6.36x4.71x2.11x5.37x6.77x
CI leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

HCA leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in HCA five years ago would be worth $20,974 today (with dividends reinvested), compared to $6,152 for ARDT. Over the past 12 months, CVS leads with a +34.7% total return vs ARDT's -30.5%. The 3-year compound annual growth rate (CAGR) favors HCA at 16.3% vs ARDT's -15.0% — a key indicator of consistent wealth creation.

MetricARDT logoARDTArdent Health Par…UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…HCA logoHCAHCA Healthcare, I…CI logoCICigna Corporation
YTD ReturnYear-to-date+14.4%+10.6%+10.6%-8.6%+2.3%
1-Year ReturnPast 12 months-30.5%-3.2%+34.7%+19.7%-13.3%
3-Year ReturnCumulative with dividends-38.5%-19.9%+36.6%+57.4%+13.6%
5-Year ReturnCumulative with dividends-38.5%-2.6%+17.0%+109.7%+18.5%
10-Year ReturnCumulative with dividends-38.5%+220.6%+3.5%+450.5%+136.5%
CAGR (3Y)Annualised 3-year return-15.0%-7.1%+11.0%+16.3%+4.4%
HCA leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

CVS leads this category, winning 2 of 2 comparable metrics.

CVS is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than ARDT's 1.40 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVS currently trades 98.5% from its 52-week high vs ARDT's 63.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricARDT logoARDTArdent Health Par…UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…HCA logoHCAHCA Healthcare, I…CI logoCICigna Corporation
Beta (5Y)Sensitivity to S&P 5001.28x0.59x0.13x0.31x0.38x
52-Week HighHighest price in past year$15.48$395.52$88.63$556.52$338.89
52-Week LowLowest price in past year$8.07$234.60$58.35$330.00$239.51
% of 52W HighCurrent price vs 52-week peak+63.8%+93.5%+98.5%+77.1%+83.8%
RSI (14)Momentum oscillator 0–10046.675.969.330.853.5
Avg Volume (50D)Average daily shares traded382K7.9M7.4M1000K1.5M
CVS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.

Analyst consensus: ARDT as "Buy", UNH as "Buy", CVS as "Buy", HCA as "Buy", CI as "Buy". Consensus price targets imply 34.9% upside for ARDT (target: $13) vs 4.2% for UNH (target: $385). For income investors, CVS offers the higher dividend yield at 3.06% vs HCA's 0.69%.

MetricARDT logoARDTArdent Health Par…UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…HCA logoHCAHCA Healthcare, I…CI logoCICigna Corporation
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuyBuy
Price TargetConsensus 12-month target$13.33$385.43$96.75$527.45$328.00
# AnalystsCovering analysts1252414639
Dividend YieldAnnual dividend ÷ price+2.4%+3.1%+0.7%+2.1%
Dividend StreakConsecutive years of raises125056
Dividend / ShareAnnual DPS$8.70$2.67$2.94$6.06
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.7%0.0%+10.5%+4.8%
Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.
Key Takeaway

HCA leads in 2 of 6 categories (Income & Cash Flow, Total Returns). ARDT leads in 1 (Valuation Metrics). 1 tied.

Best OverallHCA Healthcare, Inc. (HCA)Leads 2 of 6 categories
Loading custom metrics...

ARDT vs UNH vs CVS vs HCA vs CI: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is ARDT or UNH or CVS or HCA or CI a better buy right now?

For growth investors, UnitedHealth Group Incorporated (UNH) is the stronger pick with 11.

8% revenue growth year-over-year, versus 6. 0% for Ardent Health Partners, LLC (ARDT). Ardent Health Partners, LLC (ARDT) offers the better valuation at 10. 3x trailing P/E (9. 0x forward), making it the more compelling value choice. Analysts rate Ardent Health Partners, LLC (ARDT) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ARDT or UNH or CVS or HCA or CI?

On trailing P/E, Ardent Health Partners, LLC (ARDT) is the cheapest at 10.

3x versus CVS Health Corporation at 62. 8x. On forward P/E, Ardent Health Partners, LLC is actually cheaper at 9. 0x.

03

Which is the better long-term investment — ARDT or UNH or CVS or HCA or CI?

Over the past 5 years, HCA Healthcare, Inc.

(HCA) delivered a total return of +109. 7%, compared to -38. 5% for Ardent Health Partners, LLC (ARDT). Over 10 years, the gap is even starker: HCA returned +457. 9% versus ARDT's -37. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ARDT or UNH or CVS or HCA or CI?

By beta (market sensitivity over 5 years), CVS Health Corporation (CVS) is the lower-risk stock at 0.

13β versus Ardent Health Partners, LLC's 1. 28β — meaning ARDT is approximately 884% more volatile than CVS relative to the S&P 500. On balance sheet safety, Cigna Corporation (CI) carries a lower debt/equity ratio of 75% versus 134% for Ardent Health Partners, LLC — giving it more financial flexibility in a downturn.

05

Which is growing faster — ARDT or UNH or CVS or HCA or CI?

By revenue growth (latest reported year), UnitedHealth Group Incorporated (UNH) is pulling ahead at 11.

8% versus 6. 0% for Ardent Health Partners, LLC (ARDT). On earnings-per-share growth, the picture is similar: Cigna Corporation grew EPS 82. 9% year-over-year, compared to -62. 0% for CVS Health Corporation. Over a 3-year CAGR, CI leads at 15. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ARDT or UNH or CVS or HCA or CI?

HCA Healthcare, Inc.

(HCA) is the more profitable company, earning 9. 0% net margin versus 0. 4% for CVS Health Corporation — meaning it keeps 9. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCA leads at 15. 8% versus 2. 6% for CVS. At the gross margin level — before operating expenses — ARDT leads at 97. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ARDT or UNH or CVS or HCA or CI more undervalued right now?

On forward earnings alone, Ardent Health Partners, LLC (ARDT) trades at 9.

0x forward P/E versus 20. 2x for UnitedHealth Group Incorporated — 11. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ARDT: 34. 9% to $13. 33.

08

Which pays a better dividend — ARDT or UNH or CVS or HCA or CI?

In this comparison, CVS (3.

1% yield), UNH (2. 4% yield), CI (2. 1% yield), HCA (0. 7% yield) pay a dividend. ARDT does not pay a meaningful dividend and should not be held primarily for income.

09

Is ARDT or UNH or CVS or HCA or CI better for a retirement portfolio?

For long-horizon retirement investors, HCA Healthcare, Inc.

(HCA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 31), 0. 7% yield, +457. 9% 10Y return). Both have compounded well over 10 years (HCA: +457. 9%, ARDT: -37. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ARDT and UNH and CVS and HCA and CI?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ARDT is a small-cap deep-value stock; UNH is a large-cap quality compounder stock; CVS is a mid-cap income-oriented stock; HCA is a mid-cap deep-value stock; CI is a mid-cap deep-value stock. UNH, CVS, HCA, CI pay a dividend while ARDT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

ARDT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 36%
Run This Screen
Stocks Like

UNH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Dividend Yield > 0.9%
Run This Screen
Stocks Like

CVS

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 1.2%
Run This Screen
Stocks Like

HCA

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

CI

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Dividend Yield > 0.8%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ARDT and UNH and CVS and HCA and CI on the metrics below

Revenue Growth>
%
(ARDT: 7.0% · UNH: 2.0%)
Net Margin>
%
(ARDT: 2.1% · UNH: 2.7%)
P/E Ratio<
x
(ARDT: 10.3x · UNH: 27.9x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.